SCHEMBL14865730

SCHEMBL14865730

CCCCOC(=O)CCSCC(O)COCCOCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G4B P0C869 1/20 0.50
KDM4E B2RXH2 1/20 0.38
DUSP3 P51452 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
LMNA P02545 1/20 0.38
DGKA P23743 1/20 0.38
LPAR5 Q9H1C0 2/20 0.37
LPAR6 P43657 1/20 0.37
LPAR1 Q92633 1/20 0.37
LPAR4 Q99677 1/20 0.37
LPAR2 Q9HBW0 1/20 0.37
LPAR3 Q9UBY5 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
ENPP2 Q13822 1/20 0.37
MAPT P10636 1/20 0.37
USP2 O75604 1/20 0.36
HTR2C P28335 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14865721 0.85 PLA2G4B (0.41) PLA2G4BLPAR5CYP1A2CYP3A4CYP2C19
SCHEMBL14732243 0.83 KDM4E (0.49) PLA2G4BKDM4EDUSP3MEN1KMT2A
SCHEMBL14865692 0.81 PLA2G4B (0.55) PLA2G4BKMT2ALMNACYP1A2CYP3A4
SCHEMBL10606514 0.79 LMNA (0.49) PLA2G4BKDM4EDUSP3MEN1KMT2A
SCHEMBL14865731 0.78 USP2 (0.50) PLA2G4BMEN1KMT2ALPAR5CYP1A2
SCHEMBL14732233 0.78 KDM4E (0.54) PLA2G4BKDM4EDUSP3MEN1KMT2A
SCHEMBL14732234 0.78 KDM4E (0.54) PLA2G4BKDM4EDUSP3MEN1KMT2A
SCHEMBL10338675 0.78 DGKA (0.53) PLA2G4BMEN1KMT2ADGKACYP3A4
SCHEMBL112324 0.77 DGKA (0.55) PLA2G4BDGKAMAPTHTR2CNAAA
SCHEMBL17974565 0.76 DGKA (0.53) LMNADGKAMAPTHTR2CNAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530559-B2 Composite of organic compound and copper nanoparticles, composite of organic compound and copper(I) oxide nanoparticles, and methods for producing the composites DIC CORPORATION (JP) 2013-09-10 US disclosed
US-20130095320-A1 COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES DIC CORPORATION (JP) 2013-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130095320-A1 COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES AOC3, AOC2, CORO1C PLA2G4B 4671/4885KDM4E 2618/4885DUSP3 4734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.